Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK<sub>2</sub>R Cancer Theranostic Agents: A Preclinical Study
(1) Background: Theranostic approaches in the management of cholecystokinin subtype 2 receptor (CCK<sub>2</sub>R)-positive tumors include radiolabeled gastrin and CCK motifs. Moving toward antagonist-based CCK<sub>2</sub>R-radioligands instead, we herein present three analogs...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |